# Emtricitabine and Tenofovir Disoproxil Fumarate

NDC: 0378-1930
Generic name: Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210330
Marketing ended: 20260531
FDA application: ANDA206436

## Active ingredients

- EMTRICITABINE: 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-1930"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-1930
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d21888d6-d5a8-49fe-9e07-e854cf78b712